A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Tahseen Mozaffar, MD
University of California Irvine Health
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Vancouver General Hospital
Vancouver, British Columbia, Canada
- the Ottawa Hospital
Ottawa, Ontario, Canada
- Montreal Neurological Hospital
Montreal, Quebec, Canada
- Rigshospitalet
Copenhagen, Denmark
- Centre Hospitalier Universitaire D'Angers
Angers, France
- Chu Paris Idf Ouest - Hôpital Raymond Poincaré
Garches, France
- Centre Hospitalier Régional Universitaire de Lille
Lille, France
- Assistance Publique Hôpitaux de Marseille
Marseille, France
- Nice University Hospital
Nice, France
- Friedrich-Baur-Institut Neurologische Klinik Ludwig-Maximilians-Universität München
München, Germany
- Universita Degli Studi Di Messina - Dipartimento Di Medicina Clinica E Sperimentale
Messina, Italy
- Universita Degli Studi Di Milano, Laboratorio Di Biochimica E Genetica Della Malattie Neuromuscolari
Milan, Italy
- Malattie Metaboliche Universita Degli Studi Di Napoli Federico Ii
Naples, Italy
- Uo Neurologia Azienda Ospedaliera Universitaria Pisana
Pisa, Italy
- Azienda Ospedaliera Universitaria Città Della Salute E Della Scienza Di Torino - Neurology, Osp. Molinette
Torino, Italy
- Erasmus Medical Center
Rotterdam, Netherlands
- New Queen Elizabeth Hospital Birmingham
Birmingham, GBR, United Kingdom
- the Royal Free London Nhs Foundation Trust
London, GBR, United Kingdom
- Salford Royal Mhs Foundation Trust
Salford, United Kingdom
- Barrow Neurological Institute
Phoenix, Arizona, United States
- University of California Irvine Health
Orange, California, United States
- Emory University School of Medicine
Atlanta, Georgia, United States
- University of Kansas Medical Center Research Institute
Kansas City, Kansas, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Oregon Health & Science University
Portland, Oregon, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- University of Utah
Salt Lake City, Utah, United States
- Lysosomal and Rare Disorders Research & Treatment Center
Fairfax, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Oct 2020
- Primary completion
- 30 Apr 2032
- Completion
- 30 Apr 2032
- Last update posted
- 27 Nov 2024
- Registered enrollment
- 4
- Registry id
- NCT04093349
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.